Intracellular antibody‐mediated immunity and the role of TRIM21
暂无分享,去创建一个
[1] J. Yewdell,et al. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands , 2011, Cellular and Molecular Life Sciences.
[2] Jeremy Luban,et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.
[3] H. Erdjument-Bromage,et al. Fas-associated Death Domain (FADD) and the E3 Ubiquitin-Protein Ligase TRIM21 Interact to Negatively Regulate Virus-induced Interferon Production* , 2010, The Journal of Biological Chemistry.
[4] L. James,et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) , 2010, Proceedings of the National Academy of Sciences.
[5] R. Fuchs,et al. Uncoating of human rhinoviruses , 2010, Reviews in medical virology.
[6] T. Kamitani,et al. Cytoplasmic relocation of Daxx induced by Ro52 and FLASH , 2010, Histochemistry and Cell Biology.
[7] R. Higgs,et al. Self Protection from Anti-Viral Responses – Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors , 2010, PloS one.
[8] K. Ozato,et al. Comment on “Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts” , 2009, The Journal of Immunology.
[9] K. Wada,et al. Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling. , 2009, Journal of biochemistry.
[10] V. Kuchroo,et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathway , 2009, The Journal of experimental medicine.
[11] K. Ozato,et al. Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts1 , 2009, The Journal of Immunology.
[12] S. Inoue,et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. , 2009, Cell host & microbe.
[13] She Chen,et al. TRIM21 Is Essential to Sustain IFN Regulatory Factor 3 Activation during Antiviral Response1 , 2009, The Journal of Immunology.
[14] R. Higgs,et al. The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN-β Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF31 , 2008, The Journal of Immunology.
[15] A. Ballabio,et al. Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties , 2008, BMC Evolutionary Biology.
[16] L. James,et al. TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved , 2008, Proceedings of the National Academy of Sciences.
[17] E. De Clercq,et al. Recovery of Humoral Immunity Is Critical for Successful Antiviral Therapy in Disseminated Mouse Adenovirus Type 1 Infection , 2008, Antimicrobial Agents and Chemotherapy.
[18] F. Bushman,et al. The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22 , 2008, PLoS pathogens.
[19] D. Burton,et al. Fc receptor but not complement binding is important in antibody protection against HIV , 2007, Nature.
[20] Hyun Kook Cho,et al. Cutting Edge: Autoantigen Ro52 Is an Interferon Inducible E3 Ligase That Ubiquitinates IRF-8 and Enhances Cytokine Expression in Macrophages1 , 2007, The Journal of Immunology.
[21] J. Trowsdale,et al. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function , 2007, Proceedings of the National Academy of Sciences.
[22] D. Griffin,et al. Synergistic Roles of Antibody and Interferon in Noncytolytic Clearance of Sindbis Virus from Different Regions of the Central Nervous System , 2007, Journal of Virology.
[23] Y. Kawaoka,et al. Protective efficacy of neutralizing antibodies against Ebola virus infection. , 2007, Vaccine.
[24] Andrea Michael Meyer,et al. Regulation of p27 Degradation and S-Phase Progression by Ro52 RING Finger Protein , 2006, Molecular and Cellular Biology.
[25] C. Cunningham-Rundles,et al. X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients , 2006, Medicine.
[26] Carl S. Goodyear,et al. Confounding B-cell defences: lessons from a staphylococcal superantigen , 2006, Nature Reviews Immunology.
[27] K. Smith,et al. Insights into post-infectious bronchiolitis obliterans in children , 2006, Thorax.
[28] G. Diette,et al. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis , 2006, Thorax.
[29] S. Nisole,et al. TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.
[30] K. Reimann,et al. Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus , 2005, Nature Medicine.
[31] H. Billett,et al. Chronic parvovirus infection and G6PD deficiency masquerading as Diamond–Blackfan anemia , 2005, American journal of hematology.
[32] E. Herlenius,et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block , 2005, The Journal of experimental medicine.
[33] Corrie Brown,et al. Fatal Disseminated Mouse Adenovirus Type 1 Infection in Mice Lacking B Cells or Bruton's Tyrosine Kinase , 2004, Journal of Virology.
[34] A. Plebani,et al. Search for poliovirus long-term excretors among patients affected by agammaglobulinemia. , 2004, Clinical immunology.
[35] John Savill,et al. A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.
[36] R. Jonsson,et al. Subcellular Redistribution and Surface Exposure of the Ro52, Ro60 and La48 Autoantigens During Apoptosis in Human Ductal Epithelial Cells: a Possible Mechanism in the Pathogenesis of Sjögren's Syndrome , 2002, Scandinavian journal of immunology.
[37] Q. Sattentau,et al. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. , 2002, The Journal of general virology.
[38] V. Fadok,et al. Apoptotic cell removal , 2001, Current Biology.
[39] Alessandro Guffanti,et al. The tripartite motif family identifies cell compartments , 2001, The EMBO journal.
[40] P. Iannetti,et al. Low-dosage immunoglobulins for an infant with hypogammaglobulinemia, maple syrup urine disease, and parvovirus B19-associated aplastic crisis. , 2000, Journal of pediatric hematology/oncology.
[41] F. Rodríguez,et al. The role of B lymphocytes in coxsackievirus B3 infection. , 1999, The American journal of pathology.
[42] O. Ruuskanen,et al. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. , 1999, American journal of respiratory and critical care medicine.
[43] J. Segovia,et al. Severe Leukopenia and Dysregulated Erythropoiesis in SCID Mice Persistently Infected with the Parvovirus Minute Virus of Mice , 1999, Journal of Virology.
[44] V. Fadok,et al. Apoptosis: Getting rid of the bodies , 1998, Current Biology.
[45] R. Voll,et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.
[46] H. de Thé,et al. Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein , 1998, Journal of Virology.
[47] M. Satoh,et al. Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. , 1997, The Journal of rheumatology.
[48] A. Levinson,et al. B-Cell superantigens: Definition and potential impact on the immune response , 1995, Journal of Clinical Immunology.
[49] J. Ahearn,et al. Novel packages of viral and self-antigens are generated during apoptosis , 1995, The Journal of experimental medicine.
[50] P. D'eufemia,et al. Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy. , 1994, The Pediatric infectious disease journal.
[51] A. Rosen,et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.
[52] Ari Helenius,et al. Stepwise dismantling of adenovirus 2 during entry into cells , 1993, Cell.
[53] A. Mosser,et al. Postabsorption neutralization of poliovirus , 1993, Journal of virology.
[54] T S Baker,et al. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.
[55] E. Moxon,et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review , 1992, Journal of Clinical Immunology.
[56] W. Schleif,et al. Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody , 1992, Nature.
[57] D. Lyles,et al. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus , 1991, Journal of virology.
[58] L. Pirofski,et al. Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye syndrome. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[59] E. Ben-Chetrit,et al. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. , 1990, Arthritis and rheumatism.
[60] F. K. Pedersen,et al. Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia , 1989, European Journal of Pediatrics.
[61] R. Levinsky,et al. Dual meningoencephalitis with echovirus type 11 and adenovirus in combined (common variable) immunodeficiency. , 1988, The Pediatric infectious disease journal.
[62] K. Sullivan,et al. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle , 1988, The Journal of experimental medicine.
[63] S. Katz,et al. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. , 1987, Reviews of infectious diseases.
[64] L. Kjellén. A hypothesis accounting for the effect of the host cell on neutralization-resistant virus. , 1985, The Journal of general virology.
[65] H. Moutsopoulos,et al. Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. , 1985, Annals of the rheumatic diseases.
[66] E. Wimmer,et al. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization , 1983, Journal of virology.
[67] A. Villarreal,et al. Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection , 1983, Infection and immunity.
[68] R. Rueckert,et al. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. , 1983, Virology.
[69] E. Wimmer,et al. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies , 1983, Journal of virology.
[70] S. Dikman,et al. Fatal disseminated adenovirus 11 pneumonia in an agammaglobulinemic patient. , 1981, The American journal of medicine.
[71] D. O. White,et al. Antigenic determinants of influenza virus hemagglutinin. VIII. Topography of the antigenic regions of influenza virus hemagglutinin determined by competitive radioimmunoassay with monoclonal antibodies. , 1981, Virology.
[72] F. Rosen,et al. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. , 1977, The New England journal of medicine.
[73] R. Keller. Studies on the mechanism of the enzymatic reactivation of antibody-neutralized poliovirus. , 1968, Journal of immunology.
[74] R. Dulbecco,et al. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. , 1956, Virology.
[75] K. Wada,et al. Ro52-mediated Monoubiquitination of IKK b Down-regulates NF- i B Signalling , 2009 .
[76] H. Zeichhardt,et al. Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion , 2005, Archives of Virology.
[77] P. Plotz,et al. The autoantibody repertoire: searching for order , 2003, Nature Reviews Immunology.
[78] J. Castro‐Rodriguez,et al. Recurrent pneumonia as warning manifestation for suspecting primary immunodeficiencies in children. , 2001, Journal of investigational allergology & clinical immunology.
[79] M. Mattéi,et al. The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. , 1993, American journal of human genetics.
[80] B. McManus,et al. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[81] S. Katz,et al. CHRONIC ENTEROVIRAL MENINGOENCEPHALITIS IN AGAMMAGLOBULINEMIC PATIENTS , 1988 .
[82] Claes WOHLFARTt. Neutralization of Adenoviruses: Kinetics, Stoichiometry, and Mechanisms , 2022 .